BDRX
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Biodexa announces another Serenta milestone, with 100 patients enrolled in its registrational Phase 3 trial for familial adenomatous polyposis (FAP)Oct 13, 2026
- Biodexa announced a major milestone for its Serenta registrational Phase 3 trial in FAPAug 19, 2026
- Biodexa launches support initiatives for FAP patients and treatment centers in FranceJul 29, 2026
- Health Canada approved expansion of the Phase 3 Serenta registrational trial in FAPJun 29, 2026
- Biodexa licensed Otsuka's OPB-171775 molecular glue for GIST from Phase 1 readyFeb 4, 2026